These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 3920705

  • 1. Plasma levels of haloperidol and clinical response.
    Van Putten T, Marder SR, May PR, Poland RE, O'Brien RP.
    Psychopharmacol Bull; 1985; 21(1):69-72. PubMed ID: 3920705
    [No Abstract] [Full Text] [Related]

  • 2. Absence of relationship of serum haloperidol concentration and clinical response in chronic schizophrenia: a fixed-dose study.
    Bigelow LB, Kirch DG, Braun T, Korpi ER, Wagner RL, Zalcman S, Wyatt RJ.
    Psychopharmacol Bull; 1985; 21(1):66-8. PubMed ID: 3983341
    [No Abstract] [Full Text] [Related]

  • 3. Haloperidol plasma and red blood cell levels and clinical antipsychotic response.
    Garver DL, Hirschowitz J, Glicksteen GA, Kanter DR, Mavroidis ML.
    J Clin Psychopharmacol; 1984 Jun; 4(3):133-7. PubMed ID: 6736272
    [Abstract] [Full Text] [Related]

  • 4. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia.
    Levinson I, Levine S.
    Biol Psychiatry; 1995 Aug 01; 38(3):198-200. PubMed ID: 7578667
    [No Abstract] [Full Text] [Related]

  • 5. RBC and plasma levels of haloperidol and clinical response in schizophrenia.
    Smith RC, Vroulis G, Shvartsburd A, Allen R, Lewis N, Schoolar JC, Chojnacki M, Johnson R.
    Am J Psychiatry; 1982 Aug 01; 139(8):1054-6. PubMed ID: 7091432
    [Abstract] [Full Text] [Related]

  • 6. Blood levels of haloperidol and clinical outcome in schizophrenia.
    Doddi S, Rifkin A, Karajgi B, Cooper T, Borenstein M.
    J Clin Psychopharmacol; 1994 Jun 01; 14(3):187-95. PubMed ID: 8027415
    [Abstract] [Full Text] [Related]

  • 7. Review of haloperidol blood level and clinical response: looking through the window.
    Volavka J, Cooper TB.
    J Clin Psychopharmacol; 1987 Feb 01; 7(1):25-30. PubMed ID: 3546403
    [Abstract] [Full Text] [Related]

  • 8. Haloperidol plasma levels and clinical response: a therapeutic window relationship.
    Van Putten T, Marder SR, Mintz J, Poland RE.
    Psychopharmacol Bull; 1988 Feb 01; 24(1):172-5. PubMed ID: 3387519
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Use of haloperidol in high doses in schizophrenia. Clinical, biochemical and pharmacokinetic study].
    Scatton B, Zarifian E, Bianchetti G, Cuche H, Loo H, Morselli PL.
    Encephale; 1982 Feb 01; 8(1):1-8. PubMed ID: 7094868
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of varying haloperidol plasma levels on negative symptoms in schizophrenia and schizoaffective disorder.
    Volavka J, Cooper TB, Czobor P, Meisner M.
    Psychopharmacol Bull; 1996 Feb 01; 32(1):75-9. PubMed ID: 8927679
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Haloperidol and reduced haloperidol plasma levels in selected schizophrenic patients.
    Ereshefsky L, Davis CM, Harrington CA, Jann MW, Browning JL, Saklad SR, Burch NR.
    J Clin Psychopharmacol; 1984 Jun 01; 4(3):138-42. PubMed ID: 6736273
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasma haloperidol levels and clinical response: confounding variables.
    Mavroidis ML, Garver DL, Kanter DR, Hirschowitz J.
    Psychopharmacol Bull; 1985 Jun 01; 21(1):62-5. PubMed ID: 3983340
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.